Journal
JOURNAL OF HEPATOCELLULAR CARCINOMA
Volume 2, Issue -, Pages 91-99Publisher
DOVE MEDICAL PRESS LTD
DOI: 10.2147/JHC.S48956
Keywords
vascular endothelial growth factor; angiogenesis; glucose-regulated protein 78 kDa; hepatocarcinogenesis; molecular targets
Categories
Funding
- Ministry of Education, Culture, Sports, Science, and Technology of Japan [24590955]
Ask authors/readers for more resources
Hepatocellular carcinoma (HCC) is one of the male-dominant liver diseases with poor prognosis, although treatments for HCC have been progressing in the past decades. Androgen receptor (AR) is a member of the nuclear receptor superfamily. Previous studies reported that AR was expressed in human HCC and non-HCC tissues. AR is activated both ligand-dependently and ligand-independently. The latter is associated with a mitogen-activated protein kinase-,v-akt murine thymoma viral oncogene homolog 1-, or signal-transducer and activator of transcription-signaling pathway, which has been implicated in the development of HCC. It has been reported that more than 200 RNA expression levels are altered by androgen treatment. In the liver, androgen-responsive genes are cytochrome P450s, transforming growth factor beta, vascular endothelial growth factor, and glucose-regulated protein 78kDa, which are also associated with human hepatocarcinogenesis. Recent studies also revealed that AR plays a role in cell migration and metastasis. It is possible that cross-talk among AR-signaling, endoplasmic reticulum stress, and innate immune response is important for human hepatocarcinogenesis and HCC development. This review shows that AR could play a potential role in human HCC and represent one of the important target molecules for the treatment of HCC.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available